GlassScriptPhysician profile
Amit I Patel
NPI 1336131812
$12,127.63
in general payments reported to CMS, 2019-2025
19 companies · $373 in 2025
The $373 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $118 · 2021: $108 · 2022: $758 · 2023: $6,488 · 2024: $3,916 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,125 · Travel and Lodging: $1,897 · Food and Beverage: $1,754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,125.00 |
| Travel and Lodging | $1,897.15 |
| Food and Beverage | $1,754.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $6,343.79 | 2022-2023 | Gelpoint V-Path |
| Axonics, INC. | $3,512.65 | 2022-2024 | Axonics, Bulkamid |
| Merck Sharp & Dohme LLC | $1,125.00 | 2024 | Keytruda |
| Caldera Medical, INC | $399.40 | 2019-2025 | |
| Boston Scientific Corporation | $199.69 | 2019-2025 | Axonics |
| Acessa Health INC. | $88.21 | 2020 | |
| Medtronic Vascular, INC. | $76.77 | 2019 | |
| Astellas Pharma US INC | $74.95 | 2021 | |
| Integra Lifesciences Corporation | $47.87 | 2022 | |
| Valencia Technologies Corporation | $41.08 | 2025 | Ecoin Device Kit |
| Baxter Healthcare | $36.45 | 2024 | Tisseel |
| Pfizer INC. | $35.93 | 2025 | |
| Tela Bio, INC. | $32.32 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Novo Nordisk INC | $22.06 | 2024 | Ozempic, Rybelsus |
| Alafair Biosciences, INC. | $21.42 | 2024 | Versawrap |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $19.05 | 2024 | Zeposia |
| Innovation Technologies INC | $18.60 | 2023 | Irrisept |
| Kerecis Limited | $17.45 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Avation Medical, INC. | $14.94 | 2024 | Vivally |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.